Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.

Ji Min KimSorim ChoungKyong Hye JoungJu Hee LeeHyun Jin KimBon Jeong Ku

Published in: Diabetes & metabolism journal (2018)

We analyzed circulating soluble epidermal growth factor receptor (sEGFR) levels in humans. Serum sEGFR levels were higher in subjects with newly diagnosed type 2 diabetes mellitus compared with controls. Serum sEGFR was positively correlated with glycosylated hemoglobin and serum glucose and negatively correlated with serum insulin and C-peptide levels.

Keyphrases

epidermal growth factor receptor
newly diagnosed
tyrosine kinase
advanced non small cell lung cancer
end stage renal disease
type diabetes
chronic kidney disease
prognostic factors
cardiovascular disease
metabolic syndrome
patient reported
red blood cell